Novartis FDA Panel Approval: ‘Pharma Innovation At Its Best’

The FDA panel unanimously recommended approval for the groundbreaking CAR-T leukemia treatment.
Source: Barrons

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>